At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
Cocoa +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cocoa to Improve Walking Performance in Peripheral Artery Disease
In Brief
A clinical study evaluating Cocoa and Placebo for Peripheral Artery Disease. Completed, enrolled 44 participants across 1 site.
Detailed Summary
The COCOA-PAD trial will determine whether epicatechin-rich cocoa daily for six months improves walking performance in individuals with peripheral artery disease compared to placebo.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Artery Disease
CountriesUnited States
CollaboratorsNational Institute on Aging (NIA)
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2016
Enrollment StartJan 2017
Primary CompletionOct 2019
TodayJul 2026
First PostedAug 24, 2016
Enrollment StartJan 1, 2017
Primary CompletionOct 15, 2019
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.9 years ago
Interventions
Cocoadrug
Placebodrug